Morphological changes in met5-enkephalin-immunoreactive synaptic boutons in the rat neostriatum after haloperidol decanoate treatment

European Journal of Neuroscience

Volumn 8, Issue 4, 1996, Pages 716-726

  Mijnster, M J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Antipsychotic drugs; Basal ganglia; Electron microscopy; Synaptic shape

Indexed keywords

HALOPERIDOL DECANOATE; METENKEPHALIN;

ANIMAL TISSUE; ARTICLE; CELL ULTRASTRUCTURE; IMMUNOREACTIVITY; MALE; MORPHOLOGY; NEOSTRIATUM; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPSE;

ANIMALS; CORPUS STRIATUM; DENDRITES; ENKEPHALIN, METHIONINE; HALOPERIDOL; IMMUNE SERA; MALE; MICROSCOPY, ELECTRON; RATS; RATS, WISTAR; SYNAPSES;

EID: 0029928426     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.1996.tb01257.x     Document Type: Article

References (2)

1. Angulo, A., Davis, L., Buckhart, B. and Cristoph, G. (1986) Reduction of striatal dopaminergic transmission elevates proenkephalin mRNA. Eur. J. Phannacol., 130, 341-343.
2. Arbuthnott, G. W. and Ingham, C. A. (1993) The thorny problem of what dopamine does in psychiatric disease. In Arbuthnott, G. W. and Emson, P. C. (eds), Chemical Signalling in the Basal Ganglia. Progress in Brain Research, Vol. 99. Elsevier Science Publishers, Amsterdam, pp. 341-350.